Asakura Ayako, Mihara Takahiro, Goto Takahisa
Department of Anesthesiology and Critical Care Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Department of Anesthesiology and Critical Care Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan; Department of Anesthesiology, Kanagawa Children's Medical Center, Yokohama, Japan.
PLoS One. 2015 Aug 28;10(8):e0133309. doi: 10.1371/journal.pone.0133309. eCollection 2015.
Numerous studies have demonstrated the beneficial effects of preoperative administration of oral carbohydrate (CHO) or oral rehydration solution (ORS). However, the effects of preoperative CHO or ORS on postoperative quality of recovery after anesthesia remain unclear. Consequently, the purpose of the current study was to evaluate the effect of preoperative CHO or ORS on patient recovery, using the Quality of Recovery 40 questionnaire (QoR-40).
This prospective, randomized, controlled clinical trial included American Society of Anesthesiologists (ASA) physical status 1 and 2 adult patients, who were scheduled to undergo a surgical procedure of body surface. Subjects were randomized to one of the three groups: 1) preoperative CHO group, 2) preoperative ORS group, and 3) control group. The primary outcome was the global QoR-40 administered 24 h after surgery. Intraoperative use of vasopressor, intraoperative body temperature changes, and postoperative nausea and vomiting (PONV) were also evaluated.
We studied 134 subjects. The median [interquartile range (IQR)] global QoR-40 scores 24 h after the surgery were 187 [177-197], 186 [171-200], and 184 [171-198] for the CHO, ORS, and control groups, respectively (p = 0.916). No significant differences existed between the groups regarding intraoperative vasopressor use during the surgery (p = 0.475).
Results of the current study indicated that the preoperative administration of either CHO or ORS did not improve the quality of recovery in patients undergoing minimally invasive body surface surgery.
www.umin.ac.jp UMIN000009388 https://upload.umin.ac.jp/cgi-open-bin/ctr/ctr.cgi?function=brows&action=brows&type=summary&recptno=R000011029&language=E.
大量研究已证实术前给予口服碳水化合物(CHO)或口服补液盐(ORS)的有益效果。然而,术前CHO或ORS对麻醉后术后恢复质量的影响仍不明确。因此,本研究的目的是使用恢复质量40问卷(QoR - 40)评估术前CHO或ORS对患者恢复的影响。
这项前瞻性、随机、对照临床试验纳入了美国麻醉医师协会(ASA)身体状况为1级和2级的成年患者,这些患者计划接受体表外科手术。受试者被随机分为三组之一:1)术前CHO组,2)术前ORS组,3)对照组。主要结局是术后24小时给予的总体QoR - 40。还评估了术中血管升压药的使用、术中体温变化以及术后恶心呕吐(PONV)情况。
我们研究了134名受试者。术后24小时,CHO组、ORS组和对照组的总体QoR - 40评分中位数[四分位间距(IQR)]分别为187[177 - 197]、186[171 - 200]和184[171 - 198](p = 0.916)。各组在手术期间术中血管升压药使用方面无显著差异(p = 0.475)。
本研究结果表明,术前给予CHO或ORS均未改善接受微创体表手术患者的恢复质量。
www.umin.ac.jp UMIN000009388 https://upload.umin.ac.jp/cgi - open - bin/ctr/ctr.cgi?function = brows&action = brows&type = summary&recptno = R000011029&language = E